These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. Menegola E, Di Renzo F, Broccia ML, Prudenziati M, Minucci S, Massa V, Giavini E. Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):392-8. PubMed ID: 16193500 [Abstract] [Full Text] [Related]
6. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods. Lampen A, Göttlicher M, Nau H. ALTEX; 2001 Oct; 18(2):123-6. PubMed ID: 11378687 [Abstract] [Full Text] [Related]
7. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition. Michaelis M, Suhan T, Reinisch A, Reisenauer A, Fleckenstein C, Eikel D, Gümbel H, Doerr HW, Nau H, Cinatl J. Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451 [Abstract] [Full Text] [Related]
8. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice. Okada A, Onishi Y, Yagen B, Shimshoni JA, Kaufmann D, Bialer M, Fujiwara M. Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279 [Abstract] [Full Text] [Related]
11. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice. Okada A, Noyori H, Yagen B, Shimshoni JA, Bialer M, Fujiwara M. Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722 [Abstract] [Full Text] [Related]
12. Evaluation of stereoselective anticonvulsant, teratogenic, and pharmacokinetic profile of valnoctylurea (capuride): a chiral stereoisomer of valproic acid urea derivative. Shimshoni JA, Yagen B, Wlodarczyk B, Finnell RH, Schurig V, Bialer M. Epilepsia; 2010 Mar; 51(3):323-32. PubMed ID: 19674061 [Abstract] [Full Text] [Related]
13. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. Cho HH, Park HT, Kim YJ, Bae YC, Suh KT, Jung JS. J Cell Biochem; 2005 Oct 15; 96(3):533-42. PubMed ID: 16088945 [Abstract] [Full Text] [Related]
14. Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. Göttlicher M. Ann Hematol; 2004 Oct 15; 83 Suppl 1():S91-2. PubMed ID: 15124690 [Abstract] [Full Text] [Related]
15. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Ornoy A. Reprod Toxicol; 2009 Jul 15; 28(1):1-10. PubMed ID: 19490988 [Abstract] [Full Text] [Related]
16. Multiple effects of pentyl-4-yn-VPA enantiomers: from toxicity to short-term memory enhancement. Gotfryd K, Owczarek S, Hoffmann K, Klementiev B, Nau H, Berezin V, Bock E, Walmod PS. Neuropharmacology; 2007 Mar 15; 52(3):764-78. PubMed ID: 17095022 [Abstract] [Full Text] [Related]
17. Teratology study of derivatives of tetramethylcyclopropyl amide analogues of valproic acid in mice. Okada A, Onishi Y, Aoki Y, Yagen B, Sobol E, Bialer M, Fujiwara M. Birth Defects Res B Dev Reprod Toxicol; 2006 Jun 15; 77(3):227-33. PubMed ID: 16767757 [Abstract] [Full Text] [Related]